Literature DB >> 16679694

Human herpesvirus 6 causes hepatitis in transplant recipients.

Tetsushi Yoshikawa.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16679694     DOI： 10.2169/internalmedicine.45.0147

Source DB:  PubMed          Journal:  Intern Med        ISSN： 0918-2918            Impact factor:   1.271


× No keyword cloud information.
  4 in total

1.  Frequent human herpesvirus-6 viremia but low incidence of encephalitis in double-unit cord blood recipients transplanted without antithymocyte globulin.

Authors:  Amanda L Olson; Parastoo B Dahi; Junting Zheng; Sean M Devlin; Marissa Lubin; Anne Marie Gonzales; Sergio A Giralt; Miguel-Angel Perales; Esperanza B Papadopoulos; Doris M Ponce; James W Young; Nancy A Kernan; Andromachi Scaradavou; Richard J O'Reilly; Trudy N Small; Genovefa Papanicolaou; Juliet N Barker
Journal:  Biol Blood Marrow Transplant       Date:  2014-02-16       Impact factor: 5.742

Review 2.  Chromosomally integrated human herpesvirus 6: questions and answers.

Authors:  Philip E Pellett; Dharam V Ablashi; Peter F Ambros; Henri Agut; Mary T Caserta; Vincent Descamps; Louis Flamand; Agnès Gautheret-Dejean; Caroline B Hall; Rammurti T Kamble; Uwe Kuehl; Dirk Lassner; Irmeli Lautenschlager; Kristin S Loomis; Mario Luppi; Paolo Lusso; Peter G Medveczky; Jose G Montoya; Yasuko Mori; Masao Ogata; Joshua C Pritchett; Sylvie Rogez; Edward Seto; Katherine N Ward; Tetsushi Yoshikawa; Raymund R Razonable
Journal:  Rev Med Virol       Date:  2011-11-04       Impact factor: 6.989

3.  The Link between Hypersensitivity Syndrome Reaction Development and Human Herpes Virus-6 Reactivation.

Authors:  Joshua C Pritchett; Radu M Nanau; Manuela G Neuman
Journal:  Int J Hepatol       Date:  2012-05-16

4.  Gastroenteritis, Hepatitis, Encephalopathy, and Human Herpesvirus 6 Detection in an Immunocompetent Child: Benefits and Risks of Syndromic Multiplex Molecular Panel Testing.

Authors:  Christina A Olson; Samuel R Dominguez; Steve Miller; Charles Y Chiu; Kevin Messacar
Journal:  J Pediatr       Date:  2019-06-14       Impact factor: 4.406
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.